Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublicacións en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (5)
2016
-
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
Drugs, Vol. 76, Núm. 9, pp. 925-945
2015
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Journal of Translational Medicine, Vol. 13, Núm. 1
-
PD-L1 expression as a potential predictive biomarker
The Lancet Oncology
2014
-
Awareness and understanding of cancer immunotherapy in Europe
Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835
-
Therapeutic vaccines for cancer: An overview of clinical trials
Nature Reviews Clinical Oncology, Vol. 11, Núm. 9, pp. 509-524